397 related articles for article (PubMed ID: 26194021)
21. Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience.
Alfano G; Fontana F; Colaci E; Messerotti A; Bettelli F; Potenza L; Luppi M; Cappelli G
Transplantation; 2017 Nov; 101(11):e337-e342. PubMed ID: 28731904
[TBL] [Abstract][Full Text] [Related]
22. Activated protein C resistance as measured by residual factor V after Russell's viper venom and activated protein C treatment analyzed as a continuous variable in multiple myeloma and normal controls.
Zangari M; Berno T; Zhan F; Boucher KM; Tricot G; Fink L
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):420-3. PubMed ID: 21537162
[TBL] [Abstract][Full Text] [Related]
23. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.
Greenberg AJ; Rajkumar SV; Vachon CM
Blood; 2012 Jun; 119(23):5359-66. PubMed ID: 22354002
[TBL] [Abstract][Full Text] [Related]
24. Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.
Chang SH; Luo S; O'Brian KK; Thomas TS; Colditz GA; Carlsson NP; Carson KR
Lancet Haematol; 2015 Jan; 2(1):e30-6. PubMed ID: 26034780
[TBL] [Abstract][Full Text] [Related]
25. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma.
Greenberg AJ; Rajkumar SV; Larson DR; Dispenzieri A; Therneau TM; Colby CL; Phelps TK; Kumar SK; Katzmann JA; Kyle RA; Slager SL; Vachon CM
Br J Haematol; 2012 May; 157(4):472-5. PubMed ID: 22629552
[TBL] [Abstract][Full Text] [Related]
26. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.
Bacher U; Haferlach T; Kern W; Alpermann T; Schnittger S; Haferlach C
Cancer Genet Cytogenet; 2010 Dec; 203(2):169-75. PubMed ID: 21156229
[TBL] [Abstract][Full Text] [Related]
27. What is the significance of monoclonal gammopathy of undetermined significance?
Atkin C; Richter A; Sapey E
Clin Med (Lond); 2018 Oct; 18(5):391-396. PubMed ID: 30287433
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal gammopathy of unknown significance in kidney transplanted patients: novel insights into long-term outcomes.
Meuleman MS; Mouyabi S; Gueguen J; Vicca S; Divard G; Aubert O; Bienaimé F; Arnulf B; Anglicheau D; Bridoux F; Cohen C
Nephrol Dial Transplant; 2023 Dec; 39(1):64-73. PubMed ID: 37403344
[TBL] [Abstract][Full Text] [Related]
29. Effect of Exposure to Agent Orange on the Risk of Monoclonal Gammopathy and Subsequent Transformation to Multiple Myeloma: A Single-Center Experience From the Veterans Affairs Hospital, Detroit.
Bumma N; Nagasaka M; Hemingway G; Miyashita H; Chowdhury T; Kim S; Vankayala HM; Ahmed S; Jasti P
Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):305-311. PubMed ID: 32144026
[TBL] [Abstract][Full Text] [Related]
30. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
Steiner N; Schwärzler A; Göbel G; Löscher W; Wanschitz J; Gunsilius E
Oncotarget; 2017 Jan; 8(3):5081-5091. PubMed ID: 27974705
[TBL] [Abstract][Full Text] [Related]
31. A retrospective study to evaluate the work-up and follow-up of patients with monoclonal gammopathy of undetermined significance.
Berenson JR; Yellin O; Quiery A; Brady J; Patel R; Wong SF; Colbourn D; Gravenor D; Tiffany N; Shamasunder HK; Waterman B; Melamed K; Wirtschafter E
Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):336-41. PubMed ID: 21816371
[TBL] [Abstract][Full Text] [Related]
32. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
[TBL] [Abstract][Full Text] [Related]
33. Platelet hyperactivation in multiple myeloma is also evident in patients with premalignant monoclonal gammopathy of undetermined significance.
O'Sullivan LR; Meade-Murphy G; Gilligan OM; Mykytiv V; Young PW; Cahill MR
Br J Haematol; 2021 Jan; 192(2):322-332. PubMed ID: 32478420
[TBL] [Abstract][Full Text] [Related]
34. Differences in Hospital, Emergency Room and Outpatient Visits Among Adults With and Without Monoclonal Gammopathy of Undetermined Significance.
Castañeda-Avila MA; Lapane KL; Person SD; Jesdale BM; Zhou Y; Mazor KM; Epstein MM
Cancer Control; 2022; 29():10732748221126936. PubMed ID: 36112886
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
Iwanaga M; Tomonaga M
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
Kyle RA; Rajkumar SV
Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of Monoclonal Gammopathy of Undetermined Significance (MGUS): The experience from the specialized registry of hematologic malignancies of Basse-Normandie (France).
Cabrera Q; Macro M; Hebert B; Cornet E; Collignon A; Troussard X
Cancer Epidemiol; 2014 Aug; 38(4):354-6. PubMed ID: 24880205
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal gammopathy of undeterminated significance: introduction and current clinical issues.
Klincová M; Sandecká V; Mikuláiová A; Radocha J; Maisnar V; Hájek R
Klin Onkol; 2011; 24 Suppl():S14-7. PubMed ID: 21923058
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of Monoclonal Gammopathy of Undetermined Significance in Patients Who Underwent Kidney Transplantation.
Bancu I; Cañas L; Juega FJ; Pérez M; Malumbres S; Bonet J; Lauzurica R
Transplant Proc; 2015 Oct; 47(8):2344-5. PubMed ID: 26518922
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.
Kyle RA; Durie BG; Rajkumar SV; Landgren O; Blade J; Merlini G; Kröger N; Einsele H; Vesole DH; Dimopoulos M; San Miguel J; Avet-Loiseau H; Hajek R; Chen WM; Anderson KC; Ludwig H; Sonneveld P; Pavlovsky S; Palumbo A; Richardson PG; Barlogie B; Greipp P; Vescio R; Turesson I; Westin J; Boccadoro M;
Leukemia; 2010 Jun; 24(6):1121-7. PubMed ID: 20410922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]